COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
Title : Ultrasound for diagnosing pneumonia. The place of the BLUE-protocol
Daniel A. Lichtenstein, Ambroise Pare Hospital, France
Title : Comparison between conventional endotracheal tubes and polymer-coated tubes in the development of ventilator-associated pneumonia: A systematic review and meta-analysis
Oscar Inacio, Universidade Federal de Campina Grande, Brazil
Title : Clinical significance and global burden of antibiotic resistance
Reza Nassiri, Michigan State University, United States
Title : Virus/mutation-agnostic vaccines
De chu Christopher Tang, VaxDome Inc., United States
Title : Antibiotic resistance of Enterococcus spp. strains isolated from wild and farm animals - an important non-clinical problem
Krzysztof Skowron, Nicolaus Copernicus University in Torun, Poland
Title : Challenges in implementing infection prevention and control guidelines among nurses during the COVID-19 pandemic: Insights from Nepal
Deepti KC, Glasgow Caledonian University, United Kingdom